Key takeaways
- A brain-computer interface (BCI) records brain signals, decodes them with software and uses the result to run a device. It does not read free-form thoughts.
- In a Nature Medicine study published June 15, 2026, a man with ALS used an implanted speech BCI at home for nearly 23 months and rated 79% of more than 180,000 sentences as correct or mostly correct.
- BCIs are still in clinical trials. Surgery, long-term safety, cost, and regulatory approval remain open questions.
- If you or a family member is considering a trial, talk to a neurologist and the trial team first.
A brain-computer interface records brain activity, decodes it with software, and uses it to operate an external device such as a cursor, a speech synthesizer, a wheelchair, or a robotic arm. Today BCIs give real, measurable benefit to a small number of people with severe paralysis, but only inside clinical trials. A 2012 review in Mayo Clinic Proceedings by Shih, Krusienski and Wolpaw described the field’s promise and its main hurdles. More than a decade later, the biggest question has shifted from “can it work” to “can it work safely, reliably and affordably outside a lab”.
How a BCI works
The 2012 review describes BCIs as systems that acquire brain signals, analyze them, and translate them into commands for an output device, bypassing the body’s normal nerve and muscle pathways.
- Record. Sensors pick up electrical activity from the brain.
- Decode. Software, increasingly machine learning, links patterns in that activity to an intended action.
- Act. The decoded signal moves a cursor, selects a letter, or drives synthesized speech.
- Feedback. The user sees or hears the result, and the system adjusts so both the brain and the software learn.
The decoded signal is usually tied to attempted movement or speech. In the UC Davis speech study, electrodes record brain signals as a person tries to talk, unlike reading private thoughts.
| BCI Type / Sensor | Placement & Surgical Level | Key Clinical Use Cases / Studies |
| Scalp EEG | On the scalp (Non-invasive, no surgery) | Early spelling/cursor control demonstrations |
| Electrocorticography (ECoG) | Thin strip on surface of motor cortex | UCSF speech-and-gesture avatar study |
| Intracortical Arrays | Micro-electrodes implanted inside the cortex | UC Davis home speech study (Nature Medicine, 2026) |
| Endovascular (Stentrode) | Inside blood vessels near motor cortex via catheter | Synchron COMMAND study for digital device control |
What BCIs can do today
- Speech at home. A UC Davis team led by Sergey Stavisky and David Brandman reported in Nature Medicine on June 15, 2026, the long-term use of an implanted speech BCI by Casey Harrell, who has ALS. The system decoded his attempted speech from a 125,000-word vocabulary and spoke it in a digital copy of his own voice. After caregivers learned to set it up, he used it almost daily for nearly 23 months, over 3,800 hours. Across more than 180,000 sentences, he rated 79% as correct or mostly correct and corrected 13%, according to the NIH summary.
- Speech plus gesture. In September 2026, NIH shared a UCSF proof of concept in which a surface sensor strip let three paralyzed patients convey speech and gesture through a virtual avatar.
- Computer control. Synchron’s catheter-placed Stentrode was tested in the COMMAND study, which monitored six patients for 12 months as they used it for tasks like texting, emailing, and online shopping.
Limits and risks
The results above are real, and they are also early.
- Very few participants. The home-use result comes from one person. The NIH summary says the team still plans to test the system in more participants and make it smaller, more durable, and more portable.
- Not fully accurate. Harrell rated 79% of sentences as correct or mostly correct, so roughly one in five was not, and he corrected 13% himself.
- Heavy setup. For the first 280 days, researchers visited his home two to four times a week before caregivers took over setup.
- Surgery and hardware. Implanted systems require surgery, and the 2012 review already called for hardware that is convenient, portable, safe, and able to work in all environments. Neuralink, a leading developer, reported problems soon after its first human implant in January 2024.
- Narrow eligibility. A registered trial such as MindEx lists paralysis from cervical spinal cord injury, brainstem stroke, or ALS as the target group.
- Proof of everyday value is still missing. The 2012 review called for long-term studies of real-world use by people with severe disabilities and workable ways to deliver BCIs widely. Harrell’s study is an important step, not the end of that list.
Where regulation stands
The sources I found say Synchron completed its COMMAND early feasibility study and is working with the FDA on a pivotal trial that could lead to the agency’s first premarket approval of a BCI implant. I found no report of any permanently implanted BCI already approved for routine use.
Note: Because regulatory approvals and clinical trial phases for medical devices evolve rapidly, patients and clinicians should check the latest FDA device database and ClinicalTrials.gov for updates.
If you or a family member is considering a BCI trial
- Ask your neurologist whether your diagnosis and condition meet the trial’s criteria.
- Look for registered trials on ClinicalTrials.gov. Examples include BrainGate2 and MindEx.
- Ask the trial team about surgery risks, how long the device stays in, who maintains it, what happens when the trial ends, and who pays for care.
- Be cautious about any clinic offering a “brain-computer interface” outside a registered, ethics-approved trial.
The bottom line
Brain-computer interfaces have moved from lab demonstrations toward real home use for a few people who cannot speak or move, and that is a genuine medical advance. They are still trial technology, with small numbers, surgery, imperfect accuracy, and no routine approval yet. Treat bold headlines about “mind control” with caution, and judge the field by long-term results in real homes.
Related on Scientifix Digest: Scientists Designed a Drug That Crosses Into the Brain and Fights Alzheimer’s Inflammation · Your Brain Has an Aging Clock
References & Further Reading:
Source: Shih, J. J., Krusienski, D. J., & Wolpaw, J. R. (2012). “Brain-Computer Interfaces in Medicine.” Mayo Clinic Proceedings.
https://www.mayoclinicproceedings.org/article/s0025-6196%2812%2900123-1
Shih JJ, Krusienski DJ, Wolpaw JR. Brain-computer interfaces in medicine. Mayo Clinic Proceedings. 2012;87(3):268-279. doi:10.1016/j.mayocp.2011.12.008
Card NS, Singer-Clark T, Peracha H, et al. Long-term independent use of an intracortical brain-computer interface for speech and cursor control. Nature Medicine. 2026. doi:10.1038/s41591-026-04414-6